A Hybrid Qualitative–Quantitative FMEA Model for Risk Management in Clinical Laboratory Automation: A Case Study Integrating ISO 15189:2022
Journal of Clinical Laboratory Analysis · 2026-04 · 40 (7)
DOI: 10.1002/jcla.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 14.03.2026. Verfasst von Mengqi Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Peking University Shenzhen Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Risk Management, Automation, Laboratory, Healthcare Failure Mode and Effect Analysis, Laboratories, Clinical. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Total laboratory automation (TLA) system greatly enhances testing efficiency and accuracy, yet potential process‐related risks may cause inaccurate results or delayed reports. Based on the ISO 15189:2022 standard, this study applied failure mode and effects analysis (FMEA) to systematically assess risks across three TLA systems at Peking University Shenzhen Hospital.
Methods
The Roche, Abbott, and Beckman TLA systems were evaluated across the pre‐analytical, analytical, and post‐analytical phases. Failure modes were scored for severity ( S ), occurrence ( O ) and detectability ( D ) to calculate the risk priority number (RPN = S × O × D ). To improve the objectivity of occurrence scoring, qualitative questionnaires were integrated with quantitative data from laboratory information system, equipment logs and quality control records. Targeted interventions were implemented for high‐risk nodes, and their effectiveness was subsequently reevaluated.
Results
Several common high‐risk nodes were identified across the three systems, including sample transport delay, system malfunction, and reagent failures. Targeted interventions, such as pneumatic transport systems, data visualization dashboards, and intelligent reagent management platforms, were applied accordingly. Beckman's system‐specific quality control risks were effectively mitigated through Patient‐Based Real‐Time Quality Control and reaction curve monitoring. Result‐clinical consistency was improved in the Abbott and Beckman systems via retesting and multi‐rule verification. RPN values of critical failure modes were reduced to medium or low risk.
Conclusion
By integrating ISO 15189:2022 with the FMEA approach, a standardized risk assessment model for TLA systems was established. The qualitative–quantitative integrated scoring system enhanced the objectivity of risk evaluation, while targeted intelligent interventions substantially improved the quality and safety of laboratory automation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Peking University Shenzhen Hospital, Shenzhen, China.
Zitieren
APA
Wei, M., Li, M., Lin, Y., Li, B., Xue, H., & Xia, Y. (2026). A Hybrid Qualitative–Quantitative FMEA Model for Risk Management in Clinical Laboratory Automation: A Case Study Integrating ISO 15189:2022. Journal of Clinical Laboratory Analysis, 40(7). https://doi.org/10.1002/jcla.70194
Vancouver
Wei M, Li M, Lin Y, Li B, Xue H, Xia Y. A Hybrid Qualitative–Quantitative FMEA Model for Risk Management in Clinical Laboratory Automation: A Case Study Integrating ISO 15189:2022. Journal of Clinical Laboratory Analysis. 2026;40(7). doi:10.1002/jcla.70194
BibTeX
@article{Wei2026,
author = {Wei, Mengqi and Li, Mingyang and Lin, Yu and Li, Bowen and Xue, Hao and Xia, Yong},
title = {A Hybrid Qualitative–Quantitative FMEA Model for Risk Management in Clinical Laboratory Automation: A Case Study Integrating ISO 15189:2022},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
volume = {40},
number = {7},
doi = {10.1002/jcla.70194}
}
EUVIMED